Graybill Bartz & Assoc LTD Astrazeneca PLC Transaction History
Graybill Bartz & Assoc LTD
- $271 Million
- Q1 2025
A detailed history of Graybill Bartz & Assoc LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 91 shares of AZN stock, worth $6,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91Holding current value
$6,184% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
507MCall Options Held
8.14MPut Options Held
3.15M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.88 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.76 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.42 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.16 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.13 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...